[SELECT trial] Metabolic dysfunction-associated steatohepatitis (MASH) (adults) For the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
How to Use: Apply generously to clean, dry skin
once punctured, a vial is a contamination risk with each subsequent draw
This physiological effect extends satiety duration, helping individuals feel satisfied with smaller food portions and reducing hunger frequency between meals
To further determine if the early changes in peptide/protein abundance are related to the change in C-peptide in the longer term, the trends in peptide levels during the first year were compared with the fasting C-peptide/glucose ratios at 24 months
Glucagon-like peptide-1 (GLP-1) is an incretin hormone primarily produced by enteroendocrine L-cells in the distal small intestine and colon